IMS Health, Inc.
Solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients, faster.
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance.
Work with experts in your industry all over the world. IMS Consulting Group (IMSCG) is focused exclusively on life sciences and has deep expertise in key commercial areas, including pricing and market access, brand excellence, and strategy and portfolio analysis.
Co-pay Program benefit overview and enrollment, re-enrollment, and sign in portal for program-eligible patients and healthcare professionals.
The CALM Studies are looking at an investigational drug to see if it can help adults with chronic cough.
Delivering flexible clinical development solutions designed for the specific needs of biotech companies.
The ABTECT Study is an ulcerative colitis (UC) clinical research trial evaluating how safe an investigational medication is and whether it works to help those with UC.
Co-pay Program benefit overview and enrollment, re-enrollment, and sign in portal for program-eligible patients and healthcare professionals.
Are you pregnant? Do you have uterine fibroids or endometriosis? Have you taken Orilissa or Oriahnn? You may be able to help other moms-to-be.
copay program benefit overview and enrollment, re-enrollment, and sign in portal for program-eligible patients and healthcare professionals.
human papillomavirus (hpv) vaccine clinical research study evaluating how safe the investigational vaccine is and whether it works to induce an immune response against hpv compared with an approved vaccine. if you are female, between 16-26 years of age, you may be able to participate.
Do you have dry, cracked, itchy, or inflamed skin due to moderate to severe atopic dermatitis (AD)? Are you or your child aged 12 to 64 years old? Our clinical research study may be for you. You or your child must have tried and not responded to a treatment that can affect the whole body (systemic treatment) or must have been medically advised to not use topical treatments.
ims health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance.
We’re looking for volunteers 18 years of age or above with different mental health conditions, such as MDD, anxiety, bipolar disorder, schizophrenia or PTSD, to take part in a local clinical trial.
Medical Specialty Societies can leverage modern registries to improve outcomes, generate high-quality data sets, and benefit from evidence-generation techniques to enhance knowledge and drive healthcare forward.
The RELEASE Study is looking at how safe an investigational medication is and whether it improves depression for people with bipolar I disorder.
IQVIA provides performance measurements tailored for the medical technology market, pulled from a vast, curated, and robust dataset including reference, patient-level and sales data.
We’re looking for volunteers 18 years of age or above with different mental health conditions, such as MDD, anxiety, bipolar disorder, schizophrenia or PTSD, to take part in a local clinical trial.
If you are concerned about heart disease, including AFib, stroke, or heart attack, you may be interested in finding out more about our heart disease clinical research studies.
Respiratory syncytial virus, or RSV, is a seasonal cold-like virus. RSV is a highly contagious virus affecting people of all ages, causing respiratory infections. Adults 60 years of age or older may be able to take part in an investigational vaccine clinical trial. Help us find a vaccine for RSV in adults.
